News & Insights
Press Releases
- November 3, 2026 Acuitas Therapeutics Announces Scientific Presentations at the 14th mRNA Health Conference
- October 21, 2026 Acuitas Therapeutics Highlights Advances in LNP Delivery Systems for Next-Generation mRNA Vaccines at the World Vaccine Congress, Europe
- May 20, 2026 Acuitas Therapeutics Highlights In Vivo CAR T Cell Engineering and Ionizable Lipid Quality Attributes at the 2026 ASGCT Annual Meeting
Publications
- August 7, 2026 Hioe et al. (2026) “An HIV V1V2 mRNA-LNP vaccine induces strong, cross-clade functional antibody responses in mice and rhesus macaques” Journal of Immunology.
- July 6, 2026 Marchitto et al. (2026) “Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies” Nature.
- June 10, 2026 Krooss et al. (2026) “LNP-mediated base editing reduces hepatic iron overload and modifies fibrosis- and HCC-associated gene expression in HFE-related hemochromatosis mice” Journal of Hepatology.